Ameri Holdings

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch Ameri Holdings and buy or sell other stocks, ETFs, and their options commission-free!

About AMRH

Enveric Biosciences, Inc. is a biotechnology company which engages in the development of neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, addiction, and other psychiatric disorders. The company was founded on February 28, 1994 and is headquartered in Cambridge, MA. 

CEO
Joseph Tucker, PhD
CEOJoseph Tucker, PhD
Employees
5
Employees5
Headquarters
Cambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded
1994
Founded1994
Employees
5
Employees5

AMRH Key Statistics

Market cap
767.08K
Market cap767.08K
Price-Earnings ratio
-0.02
Price-Earnings ratio-0.02
Dividend yield
Dividend yield
Average volume
67.92K
Average volume67.92K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$22.20
52 Week high$22.20
52 Week low
$1.82
52 Week low$1.82

Stock Snapshot

Ameri Holdings(AMRH) stock is priced at $1.48, giving the company a market capitalization of 767.08K. It carries a P/E multiple of -0.02.

During the trading day, Ameri Holdings(AMRH) stock saw an opening price of —, a peak of —, and a bottom of —.

Trading activity shows a volume of 0, compared to an average daily volume of 67.92K.

The stock's 52-week range extends from a low of $1.82 to a high of $22.20.

The stock's 52-week range extends from a low of $1.82 to a high of $22.20.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.